North American Vaccine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine

NVX 1.410

-6.6%

Nov 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: andy harrison who wrote (35)	10/29/1996 8:43:00 PM
From: aknahow	of 82

Andy, Finally saw the press release. To me it seems like the advisory committee will recomend NVX vaxcine for a booster shot after the standard treatment. NVX in its release points out that the market for such boosters is going to deminish as the newer treatments become available. Those who were there may know what was siad as to why the committee did not state it would advise the FDA to make wider use of the vaxcine. Perhaps Sturza was correct with his claim that the lower effectiveness is a problem re final approval or even use in the market place. At any rate we will hear tomorrow. Was this a short meeting ending at 11:30? If so the delay in the press release seems like the news was a negative. No position in the stock short or long, but interested in following it.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next